MEDIFAST INC
For the period ended Dec 31, 2024. Filed Feb 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 18, 2025
MED$13.37+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of
CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S. dollars in thousands, except per share amounts & dividend data)
| 2024 · 2023 · 2022 | |||||
|---|---|---|---|---|---|
| Revenue | $602,463 | $1,072,054 | $1,598,577 | ||
| Cost of sales | 157,840 | 296,204 | 458,163 | ||
| Gross profit | 444,623 | 775,850 | 1,140,414 | ||
| Selling, general, and administrative | 441,745 | 649,448 | 955,608 | ||
| Income from operations | 2,878 | 126,402 | 184,806 | ||
| Other income (expense) | |||||
| Interest income (expense) | 4,804 | 2,490 | (701) | ||
| Other expense | (3,895) | (95) | (46) | ||
| 909 | 2,395 | (747) | |||
| Income before provision for income taxes | 3,787 | 128,797 | 184,059 | ||
| Provision for income taxes | 1,696 | 29,382 | 40,491 | ||
| Net income | $2,091 | $99,415 | $143,568 | ||
| Earnings per share - basic | $0.19 | $9.13 | $12.82 | ||
| Earnings per share - diluted | $0.19 | $9.10 | $12.73 | ||
| Weighted average shares outstanding | |||||
| Basic | 10,930 | 10,884 | 11,195 | ||
| Diluted | 10,963 | 10,921 | 11,276 | ||
| Cash dividends declared per share | $— | $4.95 | $6.56 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.